Abivax SA

Forecast & Rating12 analysts currently cover Abivax SA, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $164.00, about 77.0% upside from the current price of $92.67. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 66.9% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Abivax SA closely still see room for the stock to rise. Data as of Sep 22, 2026; for reference only and not investment advice.